Human Hantavirus Nucleoprotein (HVNP) IgG negative control serum |
AE-310620-NC |
Alpha Diagnostics |
1 ml |
EUR 196.8 |
Human IgG antibody Laboratories manufactures the luciferase assay negative control reagents distributed by Genprice. The Luciferase Assay Negative Control reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact luciferase assay. Other Luciferase products are available in stock. Specificity: Luciferase Category: Assay Group: Negative Control
Chicken Anti-Toxoplasma gondii IgG negative control serum |
Alpha Diagnostics |
1 ml |
EUR 196.8 |
Baboon Anti-Rabies Virus IgG antiserum negative control |
Alpha Diagnostics |
1 ml |
EUR 196.8 |
Kemptide Negative Control Peptide |
Abbexa |
-
EUR 427.20
-
EUR 644.40
-
EUR 343.20
|
|
|
QVD-OPh Negative Control |
Biovision |
each |
EUR 248.4 |
QVD-OPh Negative Control |
Biovision |
each |
EUR 483.6 |
QVD-OPh Negative Control |
Biovision |
each |
EUR 705.6 |
Negative Control Luciferase Lentivirus |
BPS Bioscience |
500 µl x 2 |
EUR 860 |
Description: The Negative Control Lentivirus (Firefly Luciferase) are replication incompetent, HIV-based, VSV-G pseudo typed lentiviral particles that are ready to be transduced into almost all types of mammalian cells, including primary and non-dividing cells. The particles contain a firefly luciferase gene under the control of a minimal TATA promoter, without any additional transcriptional response elements. |
Negative Control information
pGreenZeo-mCMV Plasmid [negative control] |
SR500PA-1 |
SBI |
10 ug |
EUR 474 |
NATtrol BV Negative Control (6 X 0.15mL) |
NATBVNEG-BD |
Zeptometrix |
6 X 0.15mL |
EUR 295 |
EZSolution? Q-VD-OPh, Negative Control |
1174-1 |
Biovision |
each |
EUR 248.4 |
Expression Negative Control Lentivirus (G418) |
79902-G |
BPS Bioscience |
500 µl x 2 |
EUR 795 |
Description: The Expression Negative Control Lentivirus are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to be transduced into almost all types of mammalian cells, including primary and non-dividing cells. The controls package the same virus particles as the target expression virus, but they do not express a specific protein under the CMV promoter. _x000D_The Expression Negative Control Lentivirus (G418) expresses the gene for aminoglycoside 3' phosphotransferase, which confers resistance to kanamycin, neomycin, and geneticin (G418)._x000D_The Expression Negative Control Lentivirus (Hygromycin) expresses the gene for hygromycin B phosphotransferase, which confers resistance to Hygromycin._x000D_The Expression Negative Control Lentivirus (Puromycin) expresses the gene for puromycin N-acetyl-transferase, which confers resistance to puromycin._x000D_ _x000D_ |
ODN 2006-Type B (human, Negative Control) |
VAdv-Ly0070 |
Creative Biolabs |
5 mg |
EUR 4332 |
Description: ODN 2006-Type B, human TLR9 agonist, oligodeoxy nucleotide vaccine adjuvant. |
ODN 2216-Type A (human, Negative Control) |
VAdv-Ly0075-1mg |
Creative Biolabs |
1 mg |
EUR 1528.8 |
Description: ODN 2216-Type A, human TLR9 agonist, oligodeoxy nucleotide vaccine adjuvant. |
ODN 2216-Type A (human, Negative Control) |
VAdv-Ly0075-5mg |
Creative Biolabs |
5 mg |
EUR 4332 |
Description: ODN 2216-Type A, human TLR9 agonist, oligodeoxy nucleotide vaccine adjuvant. |
ODN 2336-Type A (human, Negative Control) |
VAdv-Ly0077-1mg |
Creative Biolabs |
1 mg |
EUR 1528.8 |
Description: ODN 2336-Type A, human TLR9 agonist, oligodeoxy nucleotide vaccine adjuvant. |
ODN 2336-Type A (human, Negative Control) |
VAdv-Ly0077-5mg |
Creative Biolabs |
5 mg |
EUR 4332 |
Description: ODN 2336-Type A, human TLR9 agonist, oligodeoxy nucleotide vaccine adjuvant. |
NATtrol Norovirus Negative Control (6 x 0.125mL) |
NATROTA-6MC |
Zeptometrix |
6 x 0.125mL |
EUR 203 |
ODN 1668-Type B (murine, Negative Control) |
VAdv-Ly0071-1mg |
Creative Biolabs |
1 mg |
EUR 1528.8 |
Description: ODN 1668-Type B, murine TLR9 agonist, oligodeoxy nucleotide vaccine adjuvant. |
ODN 1668-Type B (murine, Negative Control) |
VAdv-Ly0071-5mg |
Creative Biolabs |
5 mg |
EUR 4332 |
Description: ODN 1668-Type B, murine TLR9 agonist, oligodeoxy nucleotide vaccine adjuvant. |
ODN 2088-Type A (murine, Negative Control) |
VAdv-Ly0072-1mg |
Creative Biolabs |
1 mg |
EUR 1528.8 |
Description: ODN 2088-Type A, murine TLR9 agonist, oligodeoxy nucleotide vaccine adjuvant. |
ODN 2088-Type A (murine, Negative Control) |
VAdv-Ly0072-5mg |
Creative Biolabs |
5 mg |
EUR 4332 |
Description: ODN 2088-Type A, murine TLR9 agonist, oligodeoxy nucleotide vaccine adjuvant. |
ODN 1826-Type B (murine, Negative Control) |
VAdv-Ly0074 |
Creative Biolabs |
5 mg |
EUR 4332 |
Description: ODN 1826-Type B, murine TLR9 agonist, oligodeoxy nucleotide vaccine adjuvant. |
NATtrol EV Negative Control (6 X 0.2 mL) |
NATEVNEG-6MC |
Zeptometrix |
6 X 0.2 mL |
EUR 208 |
NATtrol EV Negative Control (6 X 0.5 mL) |
MDZ056 |
Zeptometrix |
6 X 0.2 mL |
EUR 208 |